• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Leerink Partners

Ugur Sahin zlem Treci
Pharma

BioNTech shares drop after leaders' departure announcement

While calling the departure of BioNTech CEO Uğur Şahin a "logical step," Leerink also questioned whether the company can continue to thrive.
Kevin Dunleavy Mar 10, 2026 11:28am
FDA

Vaccine makers facing increased volatility, uncertainty at FDA

Feb 13, 2026 11:12am
pharmacoeconomics Leerink

Leerink uses broad model to weigh drugs' cost-effectiveness

Feb 18, 2025 8:56am
Merck

Survey indicates Merck's Winrevair is set for 'strong uptake'

Jan 24, 2025 11:52am
Business development BD growth business growth

BMS, Merck, Amgen and more face near-term generic woes: Leerink

Nov 13, 2024 10:57am
peanuts

ARS has 'blue sky opportunity' in launching neffy, analyst says

Aug 21, 2024 12:48pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings